Limitations of sniff nasal pressure in patients with severe neuromuscular weakness

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 12, 2003, Pages 1685-1687

  Hart, N ^b   Polkey, M I ^b   Sharshar, T ^a   Falaize, L ^c   Fauroux, B ^d   Raphael J C ^a   Lofaso, F ^a,c  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Services de Physiologie   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; INSPIRATORY CAPACITY; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PRESSURE; PRIORITY JOURNAL; VITAL CAPACITY;

ADULT; FEMALE; HUMANS; INHALATION; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; MOUTH; NASAL CAVITY; NEUROMUSCULAR DISEASES; REPRODUCIBILITY OF RESULTS; RESPIRATORY MUSCLES; RHINOMANOMETRY; SEVERITY OF ILLNESS INDEX;

EID: 0348012909     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.12.1685     Document Type: Article

References (16)

1. Stefanutti D, Benoist M-R, Scheinmann P, et al. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 2000;162:1507-11.
2. Iandelli I, Gorini M, Misuri G, et al. Assessing inspiratory muscle strength in patients with neurologic and neuromuscular diseases (comparative evaluation of two non invasive techniques). Chest 2001;119:1108-13.
3. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report Chest 1999;116:521-34.
4. Heritier F, Rahm F, Pasche P, et al. Sniff nasal pressure. A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med 1994;150:1678-83.
5. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationships to age and sex. Am Rev Respir Dis 1969;99:696-702.
6. Uldry C, Fitting J-W. Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax 1995;50:371-5.
7. Wilson SH, Cooke NT, Edwards RHT, et al. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984;39:535-8.
8. Laporta D, Grassino A. Assessment of transdiaphragmatic pressure in humans. J Appl Physiol 1985;58:1469-76.
9. Quanjer PH. Stanadardized lung function testing. Eur Resp J 1993;6(suppl 16):5-30s.
10. Bland JM, Altman DG. Statistical methods for assessing between two methods of clinical measurement. Lancet 1986;i:307-10.
11. Polkey MI, Green M, Moxham J. Measurement of respiratory muscle strength. Thorax 1995;50:1131-5.
12. Lyall RA, Donaldson N, Polkey MI, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124:2000-13.
13. Fitting J-W, Paillex R, Hirt L, et al. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 1999;46:887-93.
14. Heritier F, Perret C, Fitting J-W. Maximal sniff mouth pressure compared with maximal inspiratory pressure in acute respiratory failure. Chest 1991;100:175-8.
15. DeTroyer A, Borenstein S, Cordier R. Analysis of volume restriction in patients with respiratory muscle weakness. Thorax 1980;35:603-10.
16. ATS/ERS. American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care 2002;166:518-624.